Status:
RECRUITING
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborating Sponsors:
National Cancer Institute (NCI)
University of Florida
Conditions:
Pancreatic Cancer
Pancreatic Cyst
Eligibility:
All Genders
18+ years
Brief Summary
The Florida Pancreas Collaborative wants to partner with individuals who are known to have, or are suspected to have a pancreatic lesion, tumor, cyst, mass, cancer, or pancreatitis and are undergoing ...
Eligibility Criteria
Inclusion
- Individuals who present to the GI clinic, surgery, or endoscopy at Moffitt, Florida Research Institute (FRI), or UM with a clinical suspicion for (or diagnosis of) a pancreatic lesion, cyst, mass, cancer, or pancreatitis based on symptoms, imaging, or blood-work and has not had any treatment involving their pancreas.
- Able to understand and voluntarily sign the informed consent.
- Willing to complete study questionnaire(s) and donate medical images and/or biological specimens (including blood, cystic fluid, and/or tissue) obtained at the time of standard of care procedures (biopsy, surgery, and venipuncture) after signing the informed consent document
Exclusion
- No suspicion or diagnosis of a pancreatic lesion, cyst, mass, cancer, or pancreatitis.
- Has a diagnosis of a pancreatic lesion, cyst, mass, cancer, or pancreatitis and has already undergone treatment involving the pancreas (which may involve surgery, chemo- or immuno-therapy, and/or radiation).
- Unable to provide informed consent.
- Unwilling to complete study questionnaire(s) and/or donate biological specimens or images.
Key Trial Info
Start Date :
February 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
1174 Patients enrolled
Trial Details
Trial ID
NCT04275557
Start Date
February 18 2020
End Date
June 1 2027
Last Update
December 4 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Florida Research Institute (FRI)
Lakewood Rch, Florida, United States, 34211
2
Sylvester Comprehensive Cancer Center & Jackson Memorial Hospital
Miami, Florida, United States, 33136
3
Moffitt Cancer Center
Tampa, Florida, United States, 33612